• Corpus ID: 78870485

FUNCTIONAL IMAGING OF OVARIAN CANCER

@article{Vries2010FUNCTIONALIO,
  title={FUNCTIONAL IMAGING OF OVARIAN CANCER},
  author={Ege de Vries and Thijs H. Oude Munnink and Anton G. T. Terwisscha van Scheltinga and Gooitzen M. van Dam and Adrienne H. Brouwers and An K. L. Reyners and Ate G.J. van der Zee and Marjolijn N. Lub-de Hooge},
  journal={Annals of Oncology},
  year={2010},
  volume={21},
  pages={30-30}
}
18 Citations
Brain Cancer Receptors and Targeting Strategies
TLDR
This chapter explores some of the important receptors involved in breast cancer such as estrogen receptor, progesterone receptor, and human epidermal receptor-2 as well as various formulation aspects that are currently undertaken toward BC management.
Implementation of colorectal cancer screening in Spain: main results 2006-2011.
TLDR
Comparisons by sex showed that detection rates were significantly higher in men than in women (P<0.001) and participation increased over time and has now reached an acceptable rate.
Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer
TLDR
The overall survival and progression-free survival were not found to be associated with ERβ1 expression, and the wild-type ERβ isoform, which was expressed in most study patients with colorectal cancer, does not seem to have any prognostic value for the course of the disease.
Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response.
TLDR
Ki-67 is a useful tool to predict chemosensitivity in the setting of neoadjuvant chemotherapy for invasive breast cancer but not for the triple negative breast cancer subgroup.
Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
TLDR
Findings demonstrate, for the first time, that phycocyanin may be a promising anti-neoplastic agent for treatment of triple negative breast cancers.
Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study
TLDR
Most incident prostate cancer patients in Spain are diagnosed at an early stage of an adenocarcinoma, whereas the therapeutic intervals vary among centres and are shorter for patients with a worse prognosis.
...
...